[go: up one dir, main page]

Abeln et al., 2000 - Google Patents

Molecular Genetic Analysis of Flow-Sorted and Microdissected Ovarian Tumor Cells

Abeln et al., 2000

View PDF
Document ID
8682934321986064945
Author
Abeln E
Corver W
Publication year
Publication venue
Ovarian Cancer

External Links

Snippet

Study of loss of heterozygosity (LOH) is widely used to identify chromosomal locations of putative tumor suppressor genes. In this type of analysis, DNA extracted from tumor tissue is compared with constitutive DNA from the same patient by the use of polymorphic DNA …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Darzynkiewicz et al. Analysis of cellular DNA content by flow cytometry
DK2280283T3 (en) Labeled cells for use as an internal functional control in rare cell detection assays
AU689248B2 (en) A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
McKinnon Flow cytometry: an overview
Frey Nucleic acid dyes for detection of apoptosis in live cells
Russo et al. Predictors of recurrence and survival of patients with breast cancer
US6942970B2 (en) Identifying subjects suitable for topoisomerase II inhibitor treatment
Shimizu et al. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies
Mørkve et al. Quantitation of biological tumor markers (p53, c‐myc, Ki‐67 and DNA ploidy) by multiparameter flow cytometry in non‐small‐cell lung cancer
EP0660664B1 (en) Preserved, non-infectious control cells for use in the identification of a disease through blood testing
US4906561A (en) Nuclear isolation medium and procedure for separating cell nuclei
EP0745217A1 (en) Viability probes for isolation, identification and/or analysis of cells
CN113846145A (en) Fluorescent dye stabilizer, kit containing same and related application
Jordanova et al. Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis
Abeln et al. Molecular Genetic Analysis of Flow-Sorted and Microdissected Ovarian Tumor Cells
Meyer et al. DNA flow cytometry of breast carcinoma after acetic‐acid fixation
Larsen Measurement of cytoplasmic
Abeln et al. Molecular Genetic Analysis of Flow-Sorted and Microdissected Ovarian Tumor Cells Improved Detection of Loss of Heterozygosity
US5763204A (en) Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing
Mikou et al. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas
Dowsett et al. Analysis and sorting of apoptotic cells from fine‐needle aspirates of excised human primary breast carcinomas
Stomper et al. Use of specimen mammography‐guided FNA (fine‐needle aspirates) for flow cytometric multiple marker analysis and immunophenotyping in breast cancer
Masood Prognostic factors in breast cancer
Vercelli et al. Expression of transforming growth factor‐β isoforms in the skin, kidney, pancreas and bladder in a German shepherd dog affected by renal cystadenocarcinoma and nodular dermatofibrosis
Chrisman et al. In situ hybridization and high-resolution banding of chromosomes